Page last updated: 2024-09-04

cinacalcet and Fibrosis

cinacalcet has been researched along with Fibrosis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Elrashidy, RA; Ibrahim, SE	1
Crowley, SD; Liu, BC; Liu, H; Lv, LL; Pan, MM; Tang, RN; Wu, M; Zhang, JD	1
Akizawa, T; Ito, A; Kurihara, S; Tsukamoto, Y; Yajima, A	1
Jung, S; Krämer, S; Müller, D; Peters, H; Querfeld, U; Rudolph, B	1
Baker, N; Charytan, C; Coburn, JW; Coyne, DW; Frazã O, JM; Goodman, WG; Kaplan, MR; Malluche, HH; McCary, LC; Monier-Faugere, MC; Turner, SA; Wang, G	1

Trials

1 trial(s) available for cinacalcet and Fibrosis

Article	Year
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clinical nephrology, 2008, Volume: 69, Issue:4 Topics: Biomarkers; Biopsy; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Double-Blind Method; Female; Fibrosis; Humans; Hyperparathyroidism, Secondary; Ilium; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Prospective Studies; Renal Dialysis	2008

Article

Year

An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.

Clinical nephrology, 2008, Volume: 69, Issue:4

Topics: Biomarkers; Biopsy; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Double-Blind Method; Female; Fibrosis; Humans; Hyperparathyroidism, Secondary; Ilium; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Prospective Studies; Renal Dialysis

2008

Other Studies

4 other study(ies) available for cinacalcet and Fibrosis

Article	Year
Cinacalcet as a surrogate therapy for diabetic cardiomyopathy in rats through AMPK-mediated promotion of mitochondrial and autophagic function. Toxicology and applied pharmacology, 2021, 06-15, Volume: 421 Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Cinacalcet; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Fibrosis; Hemodynamics; Male; Mitochondria, Heart; Myocytes, Cardiac; Oxidative Stress; Rats, Wistar; Signal Transduction; Streptozocin; Ventricular Remodeling	2021
Cinacalcet ameliorates cardiac fibrosis in uremic hearts through suppression of endothelial-to-mesenchymal transition. International journal of cardiology, 2014, Feb-15, Volume: 171, Issue:3 Topics: Animals; Cinacalcet; Epithelial-Mesenchymal Transition; Fibrosis; Heart Diseases; Humans; Hyperparathyroidism; Male; Naphthalenes; Rats; Rats, Wistar; Uremia	2014
Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12 Suppl 1 Topics: Aged; Bone and Bones; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Drug Therapy, Combination; Fibrosis; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Osteoblasts; Parathyroid Hormone; Renal Dialysis; Time Factors; Vitamin D	2008
Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats. Journal of hypertension, 2012, Volume: 30, Issue:11 Topics: Animals; Aortic Diseases; Base Sequence; Calcinosis; Calcitriol; Cardiomyopathies; Cinacalcet; Connective Tissue Growth Factor; Fibrosis; Male; Naphthalenes; Nephrectomy; Parathyroid Hormone; Parathyroidectomy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uremia	2012